Skip to main content
. 2020 Jun 12;9(10):1137–1146. doi: 10.1002/sctm.19-0434

FIGURE 3.

FIGURE 3

Class I anti‐HLA antibodies. A, Presence of class I HLA antibodies at baseline, 6 months, and >12 months by participant (≥12‐month data not available for participants 3, 4, 11, and 12). B, Class I HLA antibodies and baseline and 6 months by number of hCT‐MSC doses. C, Class I HLA antibodies at baseline and 6 months by lot of hCT‐MSC. D, Class I HLA antibodies by HLA match (at HLA‐A, B, C, DRB1) between hCT‐MSC donor and recipient. HLA, human leukocyte antigen; MSC, mesenchymal stromal cell